Showing 121-132 of 206 articles
NHS England requires clinical and behavioural support with tirzepatide, while a randomized withdrawal trial found continued medicine, not counselling alone, maintained weight loss.
Janis Chen's account shows what prolonged life with stage IV lung cancer can demand, while clinical sources show why one exceptional course cannot define every prognosis.
Official data show 21 confirmed MenB cases linked to Canterbury, two deaths and no further outbreak-strain cases detected in England by late April.
A surgical imaging meta-analysis, a stroke decision-support trial and a heart-failure prediction model produced useful but sharply different evidence.
Former vaccine advisers and federal officials gave conflicting accounts of ACIP's future after a judge stayed 13 appointments and the panel's recent votes.
A cell-seeded esophageal graft supported feeding and contractile function in a small pig study, but strictures, repeated procedures and the lack of a control group limit the result.
Chris Klomp said TrumpRx was not designed for most insured Americans, narrowing a White House platform promoted in sweeping drug-price terms.
The UK Covid-19 Inquiry found that overstretched health systems only narrowly avoided collapse, then set out 10 recommendations for a future pandemic.
The UK medicines regulator says NAION may affect up to 1 in 10,000 semaglutide users and requires urgent assessment if sudden vision loss occurs.
On March 18, UKHSA reported nine confirmed cases, 11 notifications under investigation and a targeted vaccine offer for up to 5,000 students.
A review of 54 randomised trials found little support for routine cannabinoid treatment across mental health and substance-use disorders.
Separate mouse and human studies examined calcium-dependent synaptic strengthening and whether creating stories improves short-delay word recall.